54 related articles for article (PubMed ID: 16681008)
1. [How do you investigate an elevated calcitonin level?].
Rikir E; Valdes-Socin H; Vroonen L; Daly A; Thiry A; Meurisse M; Beckers A
Rev Med Liege; 2006 Mar; 61(3):195-200. PubMed ID: 16681008
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer mimicking as pregnancy with pneumonia.
Mehta H; Bahuva R; Sadikot RT
Lung Cancer; 2008 Sep; 61(3):416-9. PubMed ID: 18304689
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin elevation in small cell lung cancer without ectopic production.
Kelley MJ; Becker KL; Rushin JM; Venzon D; Phelps R; Ihde DC; Bliss DP; Melby K; Snider RH; Johnson BE
Am J Respir Crit Care Med; 1994 Jan; 149(1):183-90. PubMed ID: 8111580
[TBL] [Abstract][Full Text] [Related]
4. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
5. Spurious hypercalcitoninemia in patients with nodular thyroid disease induced by heterophilic antibodies.
Kim JM; Chung KW; Kim SW; Choi SH; Min HS; Kim JN; Won WJ; Kim SK; Lee JI; Chung JH; Kim SW
Head Neck; 2010 Jan; 32(1):68-75. PubMed ID: 19536770
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis.
Llewellyn DC; Srirajaskanthan R; Vincent RP; Guy C; Drakou EE; Aylwin SJB; Grossman AB; Ramage JK; Dimitriadis GK
Endocr Connect; 2021 Apr; 10(4):447-461. PubMed ID: 33764887
[TBL] [Abstract][Full Text] [Related]
7. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E
Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
McLeod MK; Vinik AI
Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
[TBL] [Abstract][Full Text] [Related]
9. Increased apolipoprotein E gene expression and protein concentration in lung cancer tissue do not contribute to the clinical assessment of non-small cell lung cancer patients.
Trost Z; Marc J; Sok M; Cerne D
Arch Med Res; 2008 Oct; 39(7):663-7. PubMed ID: 18760194
[TBL] [Abstract][Full Text] [Related]
10. New method to identify non-small-cell lung cancer biomarker.
Hill R
Bioanalysis; 2013 Oct; 5(19):2337. PubMed ID: 24066618
[No Abstract] [Full Text] [Related]
11. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine differentiation in non-small cell lung carcinomas.
Baldi A; Groger AM; Esposito V; Di Marino MP; Ferrara N; Baldi F
In Vivo; 2000; 14(1):109-14. PubMed ID: 10757067
[TBL] [Abstract][Full Text] [Related]
13. Role of p53 and EGFR as prognostic biomarkers in stage I non-small cell lung cancer.
Donahue JM
J Surg Oncol; 2014 Aug; 110(2):97-8. PubMed ID: 24895315
[No Abstract] [Full Text] [Related]
14. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
Brockmöller J; Junker K; Multhoff G
Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
[No Abstract] [Full Text] [Related]
15. A metabolic study of patients with lung cancer and hyponatremia of malignancy.
Chute JP; Taylor E; Williams J; Kaye F; Venzon D; Johnson BE
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):888-96. PubMed ID: 16467103
[TBL] [Abstract][Full Text] [Related]
16. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
17. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
19. [Lung cancer. A therapeutic challenge].
Sörenson S
Lakartidningen; 1997 Apr; 94(16):1475-7. PubMed ID: 9173188
[No Abstract] [Full Text] [Related]
20. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA; Tsao MS
J Clin Oncol; 2010 Feb; 28(6):903-5. PubMed ID: 20100955
[No Abstract] [Full Text] [Related]
[Next] [New Search]
